Evidence map›Paper›PMID 32978601›Full record

ArticleNature protocols2020

Reference-free deconvolution, visualization and interpretation of complex DNA methylation data using DecompPipeline, MeDeCom and FactorViz.

Michael Scherer, Petr V Nazarov, Reka Toth, Shashwat Sahay, Tony Kaoma, Valentin Maurer, Nikita Vedeneev, Christoph Plass, Thomas Lengauer, Jörn Walter and 1 more

Abstract read
PubMed Publisher
In one paragraph

Article in Nature protocols, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 27 papers.

0numbers the graph read from it
0cells of the map it votes in
27citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

27 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Review
  8. Article
  9. Article
  10. Epigenetic profiling of prostate cancer reveals potential prognostic signatures.Journal of cancer research and clinical oncology · 2024
    Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Michael SchererDepartment of Genetics/Epigenetics, Saarland University, Saarbrücken, Germany.ORCID http://orcid.org/0000-0001-7990-6179
Petr V NazarovQuantitative Biology Unit, Luxembourg Institute of Health, Strassen, Luxembourg.ORCID http://orcid.org/0000-0003-3443-0298
Reka TothDivision of Cancer Epigenomics, German Cancer Research Center (DKFZ), Heidelberg, Germany.ORCID http://orcid.org/0000-0002-6096-1052
Shashwat SahayDepartment of Genetics/Epigenetics, Saarland University, Saarbrücken, Germany.
Tony KaomaQuantitative Biology Unit, Luxembourg Institute of Health, Strassen, Luxembourg.
Valentin MaurerDivision of Cancer Epigenomics, German Cancer Research Center (DKFZ), Heidelberg, Germany.
Nikita VedeneevQuansight Labs, Austin, TX, USA.
Christoph PlassDivision of Cancer Epigenomics, German Cancer Research Center (DKFZ), Heidelberg, Germany.ORCID http://orcid.org/0000-0003-2554-3952
Thomas LengauerComputational Biology, Max Planck Institute for Informatics, Saarland Informatics Campus, Saarbrücken, Germany.
Jörn WalterDepartment of Genetics/Epigenetics, Saarland University, Saarbrücken, Germany.ORCID http://orcid.org/0000-0003-0563-7417
Pavlo LutsikDivision of Cancer Epigenomics, German Cancer Research Center (DKFZ), Heidelberg, Germany. p.lutsik@dkfz.de.ORCID http://orcid.org/0000-0001-9383-8555

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

DNA methylation profiling offers unique insights into human development and diseases. Often the analysis of complex tissues and cell mixtures is the only feasible option to study methylation changes across large patient cohorts. Since DNA methylomes are highly cell type specific, deconvolution methods can be used to recover cell type-specific information in the form of latent methylation components (LMCs) from such 'bulk' samples. Reference-free deconvolution methods retrieve these components without the need for DNA methylation profiles of purified cell types. Currently no integrated and guided procedure is available for data preparation and subsequent interpretation of deconvolution results. Here, we describe a three-stage protocol for reference-free deconvolution of DNA methylation data comprising: (i) data preprocessing, confounder adjustment using independent component analysis (ICA) and feature selection using DecompPipeline, (ii) deconvolution with multiple parameters using MeDeCom, RefFreeCellMix or EDec and (iii) guided biological inference and validation of deconvolution results with the R/Shiny graphical user interface FactorViz. Our protocol simplifies the analysis and guides the initial interpretation of DNA methylation data derived from complex samples. The harmonized approach is particularly useful to dissect and evaluate cell heterogeneity in complex systems such as tumors. We apply the protocol to lung cancer methylomes from The Cancer Genome Atlas (TCGA) and show that our approach identifies the proportions of stromal cells and tumor-infiltrating immune cells, as well as associations of the detected components with clinical parameters. The protocol takes slightly >3 d to complete and requires basic R skills.

Indexed as

AlgorithmsComputational BiologyComputer SimulationData AnalysisDNA MethylationEpigenesis, GeneticEpigenomicsHumansNeoplasmsSoftware

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.